On the recordMarch 22, 2021
the time is long overdue for the U.S. Congress to summon up the courage to take on perhaps the most powerful special interest in the United States, and that is the power of the pharmaceutical industry.
Source
congress.govEditor's note · Context
Calls for Congress to confront the pharmaceutical industry's influence.
Share & report
More from Richard Burr
May 9, 2022
Ms. Kotagal's refusal to continue these common-sense measures speaks volumes of her lack of commitment to due process and transparency.
Mar 28, 2022
I want to thank you for scheduling this hearing to highlight the need for Congress to consider legislation to encourage Americans to save more for their futures.
Apr 4, 2022
The faster, more predictable, and more accountable the programs are, the more patients stand to benefit from lifesaving, innovative drugs and devices.
Apr 4, 2022
Why did FDA agree, and why did the industry agree to longer review times of 128 days on 510(k)'s and provide the agency with so much more money?
Other voices in this conversation
